nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—GABRA2—conduct disorder	0.905	1	CbGaD
Propofol—Fospropofol—GABRA2—conduct disorder	0.00894	1	CrCbGaD
Propofol—GABRB2—GABA A receptor activation—GABRA2—conduct disorder	0.00431	0.0503	CbGpPWpGaD
Propofol—GABRB3—GABA A receptor activation—GABRA2—conduct disorder	0.00401	0.0468	CbGpPWpGaD
Propofol—GABRG2—GABA A receptor activation—GABRA2—conduct disorder	0.00394	0.046	CbGpPWpGaD
Propofol—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.00344	0.0402	CbGpPWpGaD
Propofol—UGT1A6—Estrogen metabolism—COMT—conduct disorder	0.00315	0.0368	CbGpPWpGaD
Propofol—GABRB2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00264	0.0308	CbGpPWpGaD
Propofol—GABRB3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00246	0.0287	CbGpPWpGaD
Propofol—GABRG2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00241	0.0282	CbGpPWpGaD
Propofol—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00211	0.0246	CbGpPWpGaD
Propofol—UGT1A6—Oxidative Stress—MAOA—conduct disorder	0.00208	0.0243	CbGpPWpGaD
Propofol—GABRB2—GABA receptor activation—GABRA2—conduct disorder	0.0014	0.0163	CbGpPWpGaD
Propofol—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0014	0.0163	CbGpPWpGaD
Propofol—UGT1A9—Estrogen metabolism—COMT—conduct disorder	0.0014	0.0163	CbGpPWpGaD
Propofol—GABRB3—GABA receptor activation—GABRA2—conduct disorder	0.0013	0.0152	CbGpPWpGaD
Propofol—CYP1B1—Estrogen metabolism—COMT—conduct disorder	0.0013	0.0152	CbGpPWpGaD
Propofol—GABRG2—GABA receptor activation—GABRA2—conduct disorder	0.00128	0.0149	CbGpPWpGaD
Propofol—UGT1A8—Phase II conjugation—COMT—conduct disorder	0.00121	0.0142	CbGpPWpGaD
Propofol—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.00112	0.0131	CbGpPWpGaD
Propofol—UGT1A6—Phase II conjugation—COMT—conduct disorder	0.000885	0.0103	CbGpPWpGaD
Propofol—CYP1B1—Melatonin metabolism and effects—MAOA—conduct disorder	0.000883	0.0103	CbGpPWpGaD
Propofol—CYP1A2—Methylation—COMT—conduct disorder	0.000819	0.00956	CbGpPWpGaD
Propofol—GABRB2—Orphan transporters—GABRA2—conduct disorder	0.000816	0.00953	CbGpPWpGaD
Propofol—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.000802	0.00937	CbGpPWpGaD
Propofol—UGT1A6—NRF2 pathway—SLC6A4—conduct disorder	0.000779	0.00909	CbGpPWpGaD
Propofol—GABRB3—Orphan transporters—GABRA2—conduct disorder	0.00076	0.00888	CbGpPWpGaD
Propofol—GABRG2—Orphan transporters—GABRA2—conduct disorder	0.000746	0.00872	CbGpPWpGaD
Propofol—UGT1A8—Biological oxidations—COMT—conduct disorder	0.00071	0.00829	CbGpPWpGaD
Propofol—UGT1A8—Biological oxidations—MAOA—conduct disorder	0.000705	0.00823	CbGpPWpGaD
Propofol—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.000652	0.00762	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000643	0.00751	CbGpPWpGaD
Propofol—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000638	0.00745	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000599	0.007	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000588	0.00687	CbGpPWpGaD
Propofol—GABRB2—Ion channel transport—GABRA2—conduct disorder	0.000572	0.00668	CbGpPWpGaD
Propofol—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.000544	0.00635	CbGpPWpGaD
Propofol—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000543	0.00634	CbGpPWpGaD
Propofol—GABRB3—Ion channel transport—GABRA2—conduct disorder	0.000533	0.00623	CbGpPWpGaD
Propofol—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.000529	0.00618	CbGpPWpGaD
Propofol—GABRG2—Ion channel transport—GABRA2—conduct disorder	0.000524	0.00611	CbGpPWpGaD
Propofol—UGT1A6—Biological oxidations—COMT—conduct disorder	0.000518	0.00605	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000514	0.00601	CbGpPWpGaD
Propofol—UGT1A6—Biological oxidations—MAOA—conduct disorder	0.000514	0.006	CbGpPWpGaD
Propofol—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000512	0.00597	CbGpPWpGaD
Propofol—UGT1A6—Metapathway biotransformation—COMT—conduct disorder	0.000511	0.00596	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000484	0.00565	CbGpPWpGaD
Propofol—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.000458	0.00534	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000451	0.00526	CbGpPWpGaD
Propofol—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.000445	0.0052	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000442	0.00517	CbGpPWpGaD
Propofol—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000409	0.00478	CbGpPWpGaD
Propofol—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0004	0.00467	CbGpPWpGaD
Propofol—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000395	0.00461	CbGpPWpGaD
Propofol—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.000392	0.00458	CbGpPWpGaD
Propofol—UGT1A9—Phase II conjugation—COMT—conduct disorder	0.000392	0.00458	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000387	0.00452	CbGpPWpGaD
Propofol—CYP2C18—FOXA1 transcription factor network—EP300—conduct disorder	0.000371	0.00433	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—GABRA2—conduct disorder	0.000371	0.00433	CbGpPWpGaD
Propofol—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000347	0.00405	CbGpPWpGaD
Propofol—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.000345	0.00403	CbGpPWpGaD
Propofol—UGT1A9—NRF2 pathway—SLC6A4—conduct disorder	0.000345	0.00403	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—GABRA2—conduct disorder	0.000345	0.00403	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—GABRA2—conduct disorder	0.000339	0.00396	CbGpPWpGaD
Propofol—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000331	0.00386	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0003	0.0035	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—GABRA2—conduct disorder	0.000296	0.00346	CbGpPWpGaD
Propofol—CYP2C18—Biological oxidations—COMT—conduct disorder	0.00029	0.00339	CbGpPWpGaD
Propofol—CYP2C18—Biological oxidations—MAOA—conduct disorder	0.000288	0.00337	CbGpPWpGaD
Propofol—CYP2C18—Metapathway biotransformation—COMT—conduct disorder	0.000286	0.00334	CbGpPWpGaD
Propofol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000283	0.0033	CbGpPWpGaD
Propofol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000283	0.0033	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—CGA—conduct disorder	0.000269	0.00314	CbGpPWpGaD
Propofol—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000267	0.00312	CbGpPWpGaD
Propofol—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.000266	0.00311	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000264	0.00308	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000264	0.00308	CbGpPWpGaD
Propofol—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000261	0.00305	CbGpPWpGaD
Propofol—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000246	0.00288	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000233	0.00272	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000231	0.0027	CbGpPWpGaD
Propofol—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00023	0.00268	CbGpPWpGaD
Propofol—UGT1A9—Biological oxidations—COMT—conduct disorder	0.00023	0.00268	CbGpPWpGaD
Propofol—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.000228	0.00266	CbGpPWpGaD
Propofol—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.000228	0.00266	CbGpPWpGaD
Propofol—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.000226	0.00264	CbGpPWpGaD
Propofol—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.000226	0.00264	CbGpPWpGaD
Propofol—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000226	0.00264	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000225	0.00263	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000218	0.00255	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000217	0.00253	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000217	0.00253	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000215	0.00251	CbGpPWpGaD
Propofol—CYP1B1—Biological oxidations—COMT—conduct disorder	0.000214	0.0025	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000213	0.00249	CbGpPWpGaD
Propofol—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.000213	0.00248	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000211	0.00247	CbGpPWpGaD
Propofol—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.000211	0.00247	CbGpPWpGaD
Propofol—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000202	0.00236	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000199	0.00233	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CGA—conduct disorder	0.000196	0.00229	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000195	0.00228	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000186	0.00217	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000186	0.00217	CbGpPWpGaD
Propofol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000186	0.00217	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000185	0.00216	CbGpPWpGaD
Propofol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000184	0.00215	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000184	0.00215	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000182	0.00213	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000182	0.00213	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—COMT—conduct disorder	0.000178	0.00208	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—MAOA—conduct disorder	0.000177	0.00207	CbGpPWpGaD
Propofol—CYP2A6—Biological oxidations—COMT—conduct disorder	0.000177	0.00207	CbGpPWpGaD
Propofol—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.000176	0.00205	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—COMT—conduct disorder	0.000167	0.00195	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—COMT—conduct disorder	0.000166	0.00194	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—MAOA—conduct disorder	0.000166	0.00194	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—MAOA—conduct disorder	0.000165	0.00193	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—COMT—conduct disorder	0.000163	0.0019	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000162	0.0019	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000162	0.0019	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—MAOA—conduct disorder	0.000162	0.00189	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000159	0.00186	CbGpPWpGaD
Propofol—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000157	0.00184	CbGpPWpGaD
Propofol—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000144	0.00168	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000143	0.00167	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—COMT—conduct disorder	0.000143	0.00167	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000142	0.00166	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—MAOA—conduct disorder	0.000142	0.00165	CbGpPWpGaD
Propofol—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000141	0.00164	CbGpPWpGaD
Propofol—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.000141	0.00164	CbGpPWpGaD
Propofol—CYP2E1—Biological oxidations—COMT—conduct disorder	0.00014	0.00163	CbGpPWpGaD
Propofol—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.000139	0.00162	CbGpPWpGaD
Propofol—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.000138	0.00161	CbGpPWpGaD
Propofol—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.000138	0.00161	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—COMT—conduct disorder	0.000132	0.00154	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.000131	0.00153	CbGpPWpGaD
Propofol—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00013	0.00152	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—COMT—conduct disorder	0.000121	0.00142	CbGpPWpGaD
Propofol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000121	0.00142	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—COMT—conduct disorder	0.000121	0.00141	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—MAOA—conduct disorder	0.000121	0.00141	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00012	0.0014	CbGpPWpGaD
Propofol—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.000119	0.00139	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000112	0.00131	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CGA—conduct disorder	0.00011	0.00128	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000108	0.00126	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000107	0.00125	CbGpPWpGaD
Propofol—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000106	0.00124	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000104	0.00121	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000104	0.00121	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000103	0.0012	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000102	0.00119	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—COMT—conduct disorder	9.92e-05	0.00116	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—MAOA—conduct disorder	9.85e-05	0.00115	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—COMT—conduct disorder	9.84e-05	0.00115	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	9.79e-05	0.00114	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—MAOA—conduct disorder	9.77e-05	0.00114	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	9.74e-05	0.00114	CbGpPWpGaD
Propofol—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	9.7e-05	0.00113	CbGpPWpGaD
Propofol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	9.49e-05	0.00111	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.18e-05	0.00107	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	9.12e-05	0.00106	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—COMT—conduct disorder	8.85e-05	0.00103	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—MAOA—conduct disorder	8.79e-05	0.00103	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CGA—conduct disorder	8.7e-05	0.00102	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CGA—conduct disorder	8.7e-05	0.00102	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EP300—conduct disorder	8.67e-05	0.00101	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EP300—conduct disorder	8.67e-05	0.00101	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—COMT—conduct disorder	8.41e-05	0.000982	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.37e-05	0.000977	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—MAOA—conduct disorder	8.35e-05	0.000975	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	8.29e-05	0.000968	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CGA—conduct disorder	8.11e-05	0.000947	CbGpPWpGaD
Propofol—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	8.09e-05	0.000944	CbGpPWpGaD
Propofol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	7.91e-05	0.000924	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.15e-05	0.000835	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CGA—conduct disorder	6.7e-05	0.000783	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—COMT—conduct disorder	6.49e-05	0.000758	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—MAOA—conduct disorder	6.44e-05	0.000752	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	6.4e-05	0.000747	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	5.45e-05	0.000637	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CGA—conduct disorder	5.41e-05	0.000632	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CGA—conduct disorder	5.3e-05	0.000619	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—EP300—conduct disorder	5.2e-05	0.000608	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CGA—conduct disorder	5e-05	0.000583	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—COMT—conduct disorder	4.97e-05	0.00058	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—MAOA—conduct disorder	4.93e-05	0.000576	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CGA—conduct disorder	4.58e-05	0.000535	CbGpPWpGaD
Propofol—ALB—Metabolism—CGA—conduct disorder	4.55e-05	0.000532	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CGA—conduct disorder	4.09e-05	0.000477	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—COMT—conduct disorder	3.93e-05	0.000458	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—COMT—conduct disorder	3.93e-05	0.000458	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—MAOA—conduct disorder	3.9e-05	0.000455	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—MAOA—conduct disorder	3.9e-05	0.000455	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—EP300—conduct disorder	3.8e-05	0.000443	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	3.78e-05	0.000441	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CGA—conduct disorder	3.76e-05	0.000439	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CGA—conduct disorder	3.73e-05	0.000435	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—COMT—conduct disorder	3.66e-05	0.000428	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—MAOA—conduct disorder	3.64e-05	0.000425	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	3.53e-05	0.000412	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CGA—conduct disorder	3.19e-05	0.000372	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—COMT—conduct disorder	3.03e-05	0.000353	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—MAOA—conduct disorder	3.01e-05	0.000351	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CGA—conduct disorder	2.46e-05	0.000287	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—COMT—conduct disorder	2.44e-05	0.000285	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—MAOA—conduct disorder	2.42e-05	0.000283	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—COMT—conduct disorder	2.39e-05	0.000279	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—MAOA—conduct disorder	2.37e-05	0.000277	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—COMT—conduct disorder	2.25e-05	0.000263	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—MAOA—conduct disorder	2.24e-05	0.000261	CbGpPWpGaD
Propofol—ALB—Hemostasis—EP300—conduct disorder	2.17e-05	0.000254	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.17e-05	0.000254	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—EP300—conduct disorder	2.13e-05	0.000249	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—COMT—conduct disorder	2.07e-05	0.000241	CbGpPWpGaD
Propofol—ALB—Metabolism—COMT—conduct disorder	2.06e-05	0.00024	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—MAOA—conduct disorder	2.05e-05	0.00024	CbGpPWpGaD
Propofol—ALB—Metabolism—MAOA—conduct disorder	2.04e-05	0.000238	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.99e-05	0.000232	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.98e-05	0.000231	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—COMT—conduct disorder	1.85e-05	0.000215	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—MAOA—conduct disorder	1.83e-05	0.000214	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.78e-05	0.000207	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—COMT—conduct disorder	1.7e-05	0.000198	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—MAOA—conduct disorder	1.69e-05	0.000197	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—EP300—conduct disorder	1.68e-05	0.000197	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—EP300—conduct disorder	1.68e-05	0.000197	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—COMT—conduct disorder	1.68e-05	0.000196	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—MAOA—conduct disorder	1.67e-05	0.000195	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.62e-05	0.000189	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—EP300—conduct disorder	1.57e-05	0.000183	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—COMT—conduct disorder	1.44e-05	0.000168	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—MAOA—conduct disorder	1.43e-05	0.000167	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.38e-05	0.000162	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—EP300—conduct disorder	1.3e-05	0.000152	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—COMT—conduct disorder	1.11e-05	0.00013	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—MAOA—conduct disorder	1.1e-05	0.000129	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—EP300—conduct disorder	1.05e-05	0.000122	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—EP300—conduct disorder	1.03e-05	0.00012	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—EP300—conduct disorder	9.67e-06	0.000113	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—EP300—conduct disorder	8.87e-06	0.000104	CbGpPWpGaD
Propofol—ALB—Metabolism—EP300—conduct disorder	8.82e-06	0.000103	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—EP300—conduct disorder	7.91e-06	9.24e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—EP300—conduct disorder	7.28e-06	8.5e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—EP300—conduct disorder	7.22e-06	8.43e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—EP300—conduct disorder	6.17e-06	7.2e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—EP300—conduct disorder	4.76e-06	5.56e-05	CbGpPWpGaD
